Affiliations

• ¹ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
• ² Department of Gynecologic Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
• ³ Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
• ⁴ Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
• ⁵ Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
• ⁶ Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ⁷ Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA.
• ⁸ Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
• ⁹ Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
• ¹⁰ Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ¹¹ Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
• ¹² Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
• ¹³ Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec, Canada.
• ¹⁴ Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands.
• ¹⁵ Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, Nijmegen, the Netherlands.
• ¹⁶ Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
• ¹⁷ Center for Inherited Disease Research, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ¹⁸ Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
• ¹⁹ Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
• ²⁰ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
• ²¹ Genetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research and Prevention, School of Medicine, University of California-Irvine, Irvine, California, USA.
• ²² Department of Epidemiology, University of California-Irvine, Irvine, California, USA.
• ²³ N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus.
• ²⁴ 'Agii Anargiri' Cancer Hospital, Athens, Greece.
• ²⁵ Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian Albrechts University Kiel, Kiel, Germany.
• ²⁶ Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ²⁷ Department of Oncology and Pathology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
• ²⁸ Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
• ²⁹ Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain.
• ³⁰ Gynaecology Unit, Royal Marsden Hospital, London, UK.
• ³¹ Bâtiment Cheney D, Centre Léon Bérard, Lyon, France.
• ³² Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland.
• ³³ BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
• ³⁴ Department of Gynecologic Oncology, Oregon Health &Science University, Portland, Oregon, USA.
• ³⁵ Knight Cancer Institute, Oregon Health &Science University, Portland, Oregon, USA.
• ³⁶ Department of Gynecology and Obstetrics, Universtiy Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany.
• ³⁷ Division of Epidemiology, Department of Medicine, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
• ³⁸ Vanderbilt Epidemiology Center, Department of Medicine, Vanderbilt Medical School, Nashville, Tennessee, USA.
• ³⁹ Institute for Medicine and Public Health, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
• ⁴⁰ Vanderbilt-Ingram Cancer Center, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
• ⁴¹ Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain.
• ⁴² Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
• ⁴³ Institute of Biochemistry and Genetics, Ufa Science Center, Russian Academy of Sciences, Ufa, Russian Federation.
• ⁴⁴ Division of Gynecologic Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada.
• ⁴⁵ Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
• ⁴⁶ Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
• ⁴⁷ Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway.
• ⁴⁸ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
• ⁴⁹ Clinical Cancer Genetics for the City of Hope, Clinical Cancer Genetics Community Research Network, Duarte, California, USA.
• ⁵⁰ Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
• ⁵¹ Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany.
• ⁵² Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
• ⁵³ Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
• ⁵⁴ Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden.
• ⁵⁵ Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ⁵⁶ Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.
• ⁵⁷ Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK.
• ⁵⁸ Department of Cancer Epidemiology, University Hospital, Lund, Lund University, Lund, Sweden.
• ⁵⁹ Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
• ⁶⁰ Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
• ⁶¹ Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain.
• ⁶² Service de Génétique Oncologique, Institut Curie, Paris, France.
• ⁶³ Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ⁶⁴ Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
• ⁶⁵ Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
• ⁶⁶ Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy.
• ⁶⁷ Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ⁶⁸ Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
• ⁶⁹ Cancer Pathology and Prevention, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA.
• ⁷⁰ Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
• ⁷¹ Cancer Risk Program, University of California, San Francisco, San Francisco, California, USA.
• ⁷² Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁷³ University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁷⁴ Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
• ⁷⁵ Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
• ⁷⁶ Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Centre de Recherche FRSQ du Centre Hospitalier Affilié Universitaire de Québec, Quebec City, Quebec, Canada.
• ⁷⁷ Departments of Pediatrics and Medicine, Columbia University, New York, New York, USA.
• ⁷⁸ Center for Medical Genetics, Ghent University, Ghent, Belgium.
• ⁷⁹ Division of Epidemiology, Biostatistics and Preventative Medicine, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
• ⁸⁰ Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
• ⁸¹ Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
• ⁸² Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
• ⁸³ Social &Scientific Systems, Inc., Durham, North Carolina, USA.
• ⁸⁴ Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
• ⁸⁵ Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russian Federation.
• ⁸⁶ Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
• ⁸⁷ Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ⁸⁸ Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK.
• ⁸⁹ Unité d'Oncogénétique, ICO-Centre René Gauducheau, Nantes, France.
• ⁹⁰ Oncogenetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
• ⁹¹ Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital. Barcelona, Spain.
• ⁹² Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
• ⁹³ Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
• ⁹⁴ Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Pretoria, South Africa.
• ⁹⁵ Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
• ⁹⁶ Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
• ⁹⁷ Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain.
• ⁹⁸ Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
• ⁹⁹ Institute of Human Genetics, Münster, Germany.
• ¹⁰⁰ University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK.
• ¹⁰¹ Oncogenetics Team, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK.
• ¹⁰² Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ¹⁰³ Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
• ¹⁰⁴ Department of Biostatistics and Bioinformatics, Roswell Park Institute, Buffalo, New York, USA.
• ¹⁰⁵ Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
• ¹⁰⁶ Genomic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
• ¹⁰⁷ Division of Hematology and Oncology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
• ¹⁰⁸ Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France.
• ¹⁰⁹ Department of Surgery and Cancer, Imperial College London, London, UK.
• ¹¹⁰ Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
• ¹¹¹ Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada.
• ¹¹² Department of Medical Oncology, Papageorgiou, Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
• ¹¹³ Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, USA.
• ¹¹⁴ Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
• ¹¹⁵ Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel.
• ¹¹⁶ Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
• ¹¹⁷ Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, UCLA Schools of Medicine and Public Health, Los Angeles, California, USA.
• ¹¹⁸ Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
• ¹¹⁹ Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany.
• ¹²⁰ Women's Cancer, Institute for Women's Health, University College London, London, UK.
• ¹²¹ Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ¹²² Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
• ¹²³ Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
• ¹²⁴ Beatson West of Scotland Cancer Centre, Glasgow, UK.
• ¹²⁵ Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
• ¹²⁶ Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
• ¹²⁷ Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
• ¹²⁸ Department of Medicine, Royal Marsden Hospital, London, UK.
• ¹²⁹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA.
• ¹³⁰ Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
• ¹³¹ Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
• ¹³² Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), University Hospital Cologne, Cologne, Germany.
• ¹³³ Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
• ¹³⁴ Division of Nutritional Epidemiology, Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
• ¹³⁵ Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
• ¹³⁶ Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
• ¹³⁷ Institute of Genetic Medicine, Centre for Life, Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle-upon-Tyne, UK.
• ¹³⁸ Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ¹³⁹ Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
• ¹⁴⁰ Medical Genetics Unit, St George's University of London, London, UK.
• ¹⁴¹ Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
• ¹⁴² Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
• ¹⁴³ Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
• ¹⁴⁴ Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ¹⁴⁵ Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands.
• ¹⁴⁶ Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York, USA.
• ¹⁴⁷ Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Evanston, Illinois, USA.
• ¹⁴⁸ Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
• ¹⁴⁹ Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
• ¹⁵⁰ British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
• ¹⁵¹ N.N. Petrov Institute of Oncology, St. Petersburg, Russian Federation.
• ¹⁵² Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
• ¹⁵³ Department of Statistical Science, Duke University, Durham, North Carolina, USA.
• ¹⁵⁴ Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
• ¹⁵⁵ Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
• ¹⁵⁶ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
• ¹⁵⁷ Department of Molecular and Regenerative Medicine, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
• ¹⁵⁸ State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
• ¹⁵⁹ Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden.
• ¹⁶⁰ Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
• ¹⁶¹ Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA.
• ¹⁶² Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
• ¹⁶³ Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
• ¹⁶⁴ Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
• ¹⁶⁵ Department of Surgery, Breast Care Center, Daerim St. Mary's Hospital, Seoul, Republic of Korea.
• ¹⁶⁶ Department of Pathology, University of Calgary, Calgary, Alberta, Canada.
• ¹⁶⁷ Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
• ¹⁶⁸ Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong.
• ¹⁶⁹ Department of Surgery, University of Hong Kong, Hong Kong.
• ¹⁷⁰ Cancer Genetics Center and Department of Surgery, Hong Kong Sanatorium and Hospital, Hong Kong.
• ¹⁷¹ Vesalius Research Center, VIB, Leuven, Belgium.
• ¹⁷² Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium.
• ¹⁷³ Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia-San Sebastian, Spain.
• ¹⁷⁴ CIBER of Epidemiology and Public Health, Madrid, Spain.
• ¹⁷⁵ Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain.
• ¹⁷⁶ Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.
• ¹⁷⁷ Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
• ¹⁷⁸ Department of Surgery, Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea.
• ¹⁷⁹ Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.
• ¹⁸⁰ Département de Génétique, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
• ¹⁸¹ Institut Curie, PSL Research Unviersity and INSERM U900, Paris, France.
• ¹⁸² Mines Paris Tech, Fontainebleau, France.
• ¹⁸³ College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
• ¹⁸⁴ Cancer Center Wolfsburg, Clinics of Gynaecology, Wolfsburg, Germany.
• ¹⁸⁵ Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
• ¹⁸⁶ Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
• ¹⁸⁷ Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ¹⁸⁸ Juliane Marie Centre, Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
• ¹⁸⁹ INSERM U1052, CNRS UMR 5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Lyon, France.
• ¹⁹⁰ Ovarian Cancer Research (OVCARE) Program-Gynecologic Tissue Bank, Vancouver General Hospital and BC Cancer Agency, Vancouver, British Columbia, Canada.
• ¹⁹¹ Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.
• ¹⁹² Public Health Ontario, Toronto, Ontario, Canada.
• ¹⁹³ Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
• ¹⁹⁴ Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands.
• ¹⁹⁵ Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
• ¹⁹⁶ Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands.
• ¹⁹⁷ Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
• ¹⁹⁸ Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
• ¹⁹⁹ Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
• ²⁰⁰ Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
• ²⁰¹ Department of Obstetrics and Gynecology, Oregon Health &Science University, Portland, Oregon, USA.
• ²⁰² Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
• ²⁰³ Department of Laboratory Medicine and Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
• ²⁰⁴ Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ²⁰⁵ Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
• ²⁰⁶ University of Texas School of Public Health, Houston, Texas, USA.
• ²⁰⁷ Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
• ²⁰⁸ Invitae Corporation, San Francisco, California, USA.
• ²⁰⁹ Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
• ²¹⁰ Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
• ²¹¹ Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA.
• ²¹² Department of Oncology, Lund University Hospital, Lund, Sweden.
• ²¹³ Department of Obstetrics and Gynecology, Ohio State University and the James Cancer Center, Columbus, Ohio, USA.
• ²¹⁴ West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK.
• ²¹⁵ Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
• ²¹⁶ Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, UK.
• ²¹⁷ Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
• ²¹⁸ Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
• ²¹⁹ Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
• ²²⁰ Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.
• ²²¹ Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
• ²²² Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
• ²²³ IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
• ²²⁴ Department of Obstetrics and Gynecology, Medical University of Vienna and Comprehensive Cancer Center, Vienna, Austria.
• ²²⁵ Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
• ²²⁶ NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA.
• ²²⁷ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ²²⁸ Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
• ²²⁹ South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, UK.
• ²³⁰ Service de Génétique Clinique Chromosomique et Moléculaire, Centre Hospitalier Universitaire de St Etienne, St Etienne, France.
• ²³¹ Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain.
• ²³² Unité d'Oncogénétique, Centre Hospitalier Universitaire Arnaud de Villeneuve, Montpellier, France.
• ²³³ Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy.
• ²³⁴ Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
• ²³⁵ Clalit National Israeli Cancer Control Center, Haifa, Israel.
• ²³⁶ Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel.
• ²³⁷ Department of Pathology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
• ²³⁸ Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ²³⁹ Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Evanston, Illinois, USA.
• ²⁴⁰ Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
• ²⁴¹ Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ²⁴² Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
• ²⁴³ Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle Park, North Carolina, USA.
• ²⁴⁴ Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
• ²⁴⁵ Facultés de Médecin, Université Paris-Sud, Villejuif, France.
• ²⁴⁶ Institut Gustave Roussy, Villejuif, France.
• ²⁴⁷ Human Genetics Foundation (HuGeF), Turin, Italy.
• ²⁴⁸ Facultés de Médecin, Université Paris-Saclay, Paris, France.
• ²⁴⁹ Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City, Kansas, USA.
• ²⁵⁰ Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, UK.
• ²⁵¹ North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, UK.
• ²⁵² Département Oncologie Génétique, Institut Paoli-Calmettes, Marseille, France.
• ²⁵³ Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
• ²⁵⁴ Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
• ²⁵⁵ Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
• ²⁵⁶ Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida, USA.
• ²⁵⁷ Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
• ²⁵⁸ Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
• ²⁵⁹ National Human Genome Research Institute, US National Institutes of Health, Bethesda, Maryland, USA.
• ²⁶⁰ Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
• ²⁶¹ Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia.
• ²⁶² University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
• ²⁶³ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
• ²⁶⁴ Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ²⁶⁵ Magee-Womens Hospital of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
• ²⁶⁶ Latvian Biomedical Research and Study Centre, Riga, Latvia.
• ²⁶⁷ Ovarian Cancer Research (OVCARE) Program-Cheryl Brown Ovarian Cancer Outcomes Unit (CBOCOU), BC Cancer Agency, Vancouver, British Columbia, Canada.
• ²⁶⁸ Department of Medical Genetics, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge, UK.
• ²⁶⁹ Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
• ²⁷⁰ Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
• ²⁷¹ Hellenic Health Foundation, Athens, Greece.
• ²⁷² WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
• ²⁷³ Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
• ²⁷⁴ Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands.
• ²⁷⁵ Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
• ²⁷⁶ Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
• ²⁷⁷ Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
• ²⁷⁸ Institute of Medical and Human Genetics, Charité Universitätsmedizin, Campus Virchov Klinikum, Berlin, Germany.
• ²⁷⁹ Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
• ²⁸⁰ Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.
• ²⁸¹ Vanderbilt Genetics Institute and Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ²⁸² Oxford Regional Genetics Service, Churchill Hospital, Oxford, UK.
• ²⁸³ Institute of Human Genetics, University Hospital, Leipzig, Germany.
• ²⁸⁴ Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
• ²⁸⁵ Population Health Department, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
• ²⁸⁶ Biostatistics and Computational Biology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle Park, North Carolina, USA.
• ²⁸⁷ Clinical Cancer Genetics, City of Hope, Duarte, California, USA.
• ²⁸⁸ Department of Data Management Science, Stanford University School of Medicine, Stanford, California, USA.
• ²⁸⁹ Departments of Human Genetics and Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
• ²⁹⁰ Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
• ²⁹¹ Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
• ²⁹² Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
• ²⁹³ School of Women's and Children's Health, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
• ²⁹⁴ Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
• ²⁹⁵ Department of Molecular Medicine, University La Sapienza, Rome, Italy.
• ²⁹⁶ Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ²⁹⁷ Department of Preventive Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea.
• ²⁹⁸ Seoul National University Cancer Research Institute, Seoul, Republic of Korea.
• ²⁹⁹ Department of Biomedical Science, Graduate School, Seoul National University, Seoul, Republic of Korea.
• ³⁰⁰ Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
• ³⁰¹ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
• ³⁰² Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.